Information for "Acadia Drug Approval May Clear Method For Axovant Dementia Therapy"
Basic information
| Display title | Acadia Drug Approval May Clear Method For Axovant Dementia Therapy |
| Default sort key | Acadia Drug Approval May Clear Method For Axovant Dementia Therapy |
| Page length (in bytes) | 6,044 |
| Page ID | 186760 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | DaniBottomley (talk | contribs) |
| Date of page creation | 03:36, 21 November 2021 |
| Latest editor | LelaEllington6 (talk | contribs) |
| Date of latest edit | 03:05, 23 November 2021 |
| Total number of edits | 3 |
| Total number of distinct authors | 3 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
